In the context of fetal risk assessment, what is the recommended approach?

• A. Use detailed labeling and clinical judgment in conjunction with current guidelines.
• B. Rely on old pregnancy category letters only.
• C. Assume all medications are unsafe during pregnancy.
• D. Only consider maternal outcomes.

Answer: (A)

In fetal risk assessment, use up-to-date drug labeling together with current guidelines and your clinical judgment to balance maternal benefits against fetal risks. The old pregnancy category letters are too simplistic and don’t capture the nuance of how risk varies by drug, dose, timing in pregnancy, or the strength of the available evidence. Modern labeling provides specific information on pregnancy exposure, potential fetal risks, data from human and animal studies, and guidance for use in different trimesters plus alternatives and dosing considerations. Clinically, you weigh the mother’s medical needs, the severity of the condition being treated, available safer options, and how timing of exposure might affect fetal outcomes, then tailor therapy accordingly. This integrated approach goes beyond labeling alone and avoids assuming all medications are unsafe or only focusing on maternal outcomes, by considering fetal safety as part of a comprehensive risk-benefit decision.